GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioject Medical Technologies Inc (OTCPK:BJCT) » Definitions » Inventory Turnover

Bioject Medical Technologies (Bioject Medical Technologies) Inventory Turnover : 1.55 (As of Sep. 2011)


View and export this data going back to . Start your Free Trial

What is Bioject Medical Technologies Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Bioject Medical Technologies's Cost of Goods Sold for the three months ended in Sep. 2011 was $1.85 Mil. Bioject Medical Technologies's Average Total Inventories for the quarter that ended in Sep. 2011 was $1.20 Mil. Bioject Medical Technologies's Inventory Turnover for the quarter that ended in Sep. 2011 was 1.55.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bioject Medical Technologies's Days Inventory for the three months ended in Sep. 2011 was 58.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bioject Medical Technologies's Inventory-to-Revenue for the quarter that ended in Sep. 2011 was 0.38.

Bioject Medical Technologies Inventory Turnover Historical Data

The historical data trend for Bioject Medical Technologies's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioject Medical Technologies Inventory Turnover Chart

Bioject Medical Technologies Annual Data
Trend Mar01 Mar02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.16 6.38 4.70 4.34 5.17

Bioject Medical Technologies Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.49 1.38 1.06 1.55

Bioject Medical Technologies Inventory Turnover Calculation

Bioject Medical Technologies's Inventory Turnover for the fiscal year that ended in Dec. 2010 is calculated as

Inventory Turnover (A: Dec. 2010 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2010 ) / ((Total Inventories (A: Dec. 2009 ) + Total Inventories (A: Dec. 2010 )) / count )
=3.864 / ((0.868 + 0.626) / 2 )
=3.864 / 0.747
=5.17

Bioject Medical Technologies's Inventory Turnover for the quarter that ended in Sep. 2011 is calculated as

Inventory Turnover (Q: Sep. 2011 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2011 ) / ((Total Inventories (Q: Jun. 2011 ) + Total Inventories (Q: Sep. 2011 )) / count )
=1.853 / ((1.501 + 0.893) / 2 )
=1.853 / 1.197
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioject Medical Technologies  (OTCPK:BJCT) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bioject Medical Technologies's Days Inventory for the three months ended in Sep. 2011 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2011 )/Cost of Goods Sold (Q: Sep. 2011 )*Days in Period
=1.197/1.853*365 / 4
=58.95

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bioject Medical Technologies's Inventory to Revenue for the quarter that ended in Sep. 2011 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2011 ) / Revenue (Q: Sep. 2011 )
=1.197 / 3.144
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Bioject Medical Technologies Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Bioject Medical Technologies's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioject Medical Technologies (Bioject Medical Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioject Medical Technologies Inc (OTCPK:BJCT) » Definitions » Inventory Turnover
Comparable Companies
SOAN WHSI NURO ECIA UNISQ ASNB DXTR REMI IRSB QTXB GNID PEYE SSKN SKLN VPTDF AKER UEEC NEPH STXS REPR
Traded in Other Exchanges
N/A
Address
Website
http://www.bioject.com
Bioject Medical Technologies Inc commenced operations in 1985 and is a developer and manufacturer of needle-free injection therapy systems (NFITS). The Companys long-term goal is to become supplier of needle-free injection systems to the pharmaceutical and biotechnology industries. It focused its business development efforts on new and existing licensing and supply agreements with pharmaceutical and biotechnology companies, as well as numerous research agreements that could guide to long-term agreements. The Companys pipeline of prospective new partnerships remains active. It is also actively pursuing additional opportunities both domestically and overseas as it expands its current product line. The Companys Biojector 2000 system (B2000) consists of two components: a hand-held, reusable jet injector and a sterile, single-use, disposable plastic syringe capable of delivering variable doses of medication up to 1.0 mL. Drug Reconstitution System - The needle-free drug reconstitution system allows for the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. Vitajet - The Vitajet is also composed of two components, a portable injector unit and a disposable syringe. It is smaller and lower in cost than other products in its needle-free offering. ZetaJet - The ZetaJet is Biojects latest advance in needle-free delivery systems. It consists of two components, the portable injector and an auto-disabling disposable syringe. The medical equipment market is very competitive. Bioject Medical Technologies has two patents: Biojector 2000 and Vitajet. The Companys products and manufacturing operations are subject to extensive government regulations, both in the U.S. and abroad. In the U.S., the Food and Drug Administration (FDA) administers the Federal Food, Drug and Cosmetic Act (FFDCA) and has adopted regulations to administer the FFDCA.
Executives
James C Gale director 152 W 57TH STREET, 19TH FLOOR, NEW YORK NY 10019
Sanders Morris Harris Inc/fa 10 percent owner, other: See General Remarks 600 TRAVIS, SUITE 5900, HOUSTON TX 77002
David S Tierney director C/O ABLE LABORATORIES, INC., 6 HOLLYWOOD COURT, CN 1013, SOUTH PLAINFIELD NJ 07080
Edward L Flynn director, 10 percent owner 211 SOMERVILLE ROAD RTE 202N, BEDMINISTER NJ 07921
Life Sciences Opportunities Fund Ii Lp 10 percent owner 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Lof Partners Llc other: See general remarks 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Life Sciences Opportunities Fund Instittutional Ii Lp 10 percent owner 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Randal D Chase director 28 GEORGIA COURT, RICHMOND HILL A6 L4E ON7
Brigid Makes director 20245 SW 95TH AVENUE, TUALATIN OR 97062
J Michael Redmond officer: Sr. VP Bus Dev. 10 CANTERBURY ROAD, WINDHAM NH 03087
Elan Corp Plc 10 percent owner TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN 2 L2 00000
Elan International Services Ltd 10 percent owner C/O TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN L2 2
Elan Pharmaceutical Investments Ltd 10 percent owner 102 ST JAMES COURT, FIETSS SMITH FL BERM D0 9999999999
John P Gandolfo officer: CFO 62 TERRACE ROAD, WAYNE NJ 07470
Grace K Fey director 1210 CROMWELL ROAD, HALIFAX NOVA SCOTIA A5 B3H4L2

Bioject Medical Technologies (Bioject Medical Technologies) Headlines

No Headlines